Nan-Ping Weng

7PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunitySpeciation and extinctionPacific Peoples theory of change models for healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 24, 2026
T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia.

|Mar 12, 2025
General and individualized changes in T cell immunity during aging.

Nianbin Song, Mostafa A Elbahnasawy, Nan-Ping Weng

|Oct 23, 2023
SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors.

Cecily Choy, Joseph Chen, Jiangyuan Li

|Sep 01, 2022
Heterogeneity and transcriptome changes of human CD8+ T cells across nine decades of life.

Jian Lu, Raheel Ahmad, Thomas Nguyen

|Sep 23, 2021
Validation of the effectiveness of SARS-CoV-2 vaccines in older adults in "real-world" settings.

Nan-Ping Weng, Graham Pawelec

|Aug 10, 2020
Lipid Microbubble-Conjugated Anti-CD3 and Anti-CD28 Antibodies (Microbubble-Based Human T Cell Activator) Offer Superior Long-Term Expansion of Human Naive T Cells In Vitro.

Ana Lustig, Ty'Keemi Manor, Guixin Shi

Pageof 2

Frequent Collaborators

2 joint publications

Jiangyuan Li

2 joint publications

Christopher Dunn

2 joint publications

Luigi Ferrucci

2 joint publications

Humza Hemani